Running UX studies across countries? Learn how the One-Link rule, file naming standards, and daily sheets keep global research organized.
Rolling with the punches: Centralized trackers, naming standards, and daily debriefs
read more
Back to team page
Kaitlin Stinson
Director
Kaitlin brings to Bold Insight over 14 years of experience as a human factors engineer at medical device manufacturers. She has extensive experience in diabetes care products, software as medical device (SaMD), and complex drug delivery systems. Kaitlin has a passion for meeting design control and regulatory requirements while executing agile human factors programs of research. She has a BS in Psychology from Ball State University and an MS in Human Factors from Bentley University.
Bold facts
Learn more about
Kaitlin
Something unique about you summed up in one sentence:
I cycled 2,750 miles in one year.
Your favorite part of working at Bold Insight:
The dynamic, knowledgeable, and fun culture.
In your spare time (or if you had spare time), you would absolutely do this:
Ride my bike or go kayaking.
Your favorite city in the world is...and why?
Indianapolis because that’s where I see my family and friends the most.
You cannot start the day without doing this:
Drinking 40 oz of water.
Your ultimate celebrity dinner party guest list would include:
Bethanny Frankel, Lisa Vanderpump, Gizelle Bryant, & Kyle Richards
Long-term personal or professional goal?
Visit as many wine regions across the globe as possible.
Favorite quote:
“What is the cost of lies? It’s not that we’ll mistake them for the truth. The real danger is that if we hear enough lies, then we no longer recognize the truth at all.” ~ Valery Legasov
Read Kaitlin's bold insights
- Bold Insight covers global research, Asia HFE, and FDA strategy at the 2026 HFES Health Care Symposium
- Bold Insight team contributes to long-awaited ANSI/AAMI HE75:2025 update
- Bold Insight presents with Stryker, Genentech, and AbbVie at the HFES Healthcare Symposium
- Integrating FDA's new cybersecurity guidance into medical device human factors engineering processes
- Bold Insight and Eli Lilly and Company co-publish journal article on novel assessment tool to enhance medical device usability
- Bold Insight to launch AI research project at the 2024 HFES Health Care Symposium
Read our team’s latest bold insights
The QA blueprint for international consent and PII
In global UX research, consent and personally identifiable information (PII) are not “nice-to-have” administrative checkmarks. They are the legal foundation of our work. To keep your studies bulletproof, you need a robust, proactive quality assurance (QA) blueprint.
Stop repeating yourself: How to master multi-market vendor kickoffs
Why running one master kickoff is the smartest move you can make in multi-market research prep.
Your AI platform is live. But is it really serving your users’ needs?
What our research partnership with Google revealed about evaluating AI-powered tools and the questions every product team should be asking.